| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
|
Lancet Neurol
|
2006
|
9.99
|
|
2
|
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
|
Neurobiol Aging
|
2008
|
2.51
|
|
3
|
Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
|
Arch Neurol
|
2012
|
2.39
|
|
4
|
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.
|
Dement Geriatr Cogn Disord
|
2007
|
2.15
|
|
5
|
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
|
Lancet Neurol
|
2009
|
2.10
|
|
6
|
Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
|
Dement Geriatr Cogn Disord
|
2007
|
1.76
|
|
7
|
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
|
J Neurol Neurosurg Psychiatry
|
2010
|
1.50
|
|
8
|
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
|
Arch Neurol
|
2008
|
1.48
|
|
9
|
Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.
|
Arch Neurol
|
2010
|
1.35
|
|
10
|
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
|
PLoS One
|
2009
|
1.30
|
|
11
|
Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
|
Gerontologist
|
2010
|
1.20
|
|
12
|
Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease.
|
Alzheimer Dis Assoc Disord
|
2007
|
1.13
|
|
13
|
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.
|
Int J Geriatr Psychiatry
|
2010
|
1.06
|
|
14
|
Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2009
|
1.04
|
|
15
|
Patients with Lewy body dementia use more resources than those with Alzheimer's disease.
|
Int J Geriatr Psychiatry
|
2007
|
1.01
|
|
16
|
Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients.
|
Eur Neurol
|
2010
|
0.99
|
|
17
|
Predictors of long-term cognitive outcome in Alzheimer's disease.
|
Alzheimers Res Ther
|
2011
|
0.99
|
|
18
|
C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
|
Mol Immunol
|
2008
|
0.97
|
|
19
|
Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment.
|
Alzheimer Dis Assoc Disord
|
2011
|
0.97
|
|
20
|
Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2008
|
0.97
|
|
21
|
Altered CSF orexin and α-synuclein levels in dementia patients.
|
J Alzheimers Dis
|
2012
|
0.96
|
|
22
|
Cognitive impairment is undetected in medical inpatients: a study of mortality and recognition amongst healthcare professionals.
|
BMC Geriatr
|
2012
|
0.96
|
|
23
|
A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy.
|
Clin Interv Aging
|
2013
|
0.94
|
|
24
|
The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia.
|
PLoS One
|
2012
|
0.92
|
|
25
|
Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
|
Dement Geriatr Cogn Disord
|
2008
|
0.90
|
|
26
|
A Quick Test for Cognitive Speed: a measure of cognitive speed in dementia with Lewy bodies.
|
Am J Alzheimers Dis Other Demen
|
2007
|
0.89
|
|
27
|
A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease.
|
Alzheimers Res Ther
|
2010
|
0.88
|
|
28
|
Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years.
|
Neurobiol Aging
|
2010
|
0.88
|
|
29
|
Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.
|
PLoS One
|
2012
|
0.88
|
|
30
|
Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.
|
Dement Geriatr Cogn Disord
|
2009
|
0.86
|
|
31
|
Differences in survival between patients with dementia with Lewy bodies and patients with Alzheimer's disease--measured from a fixed cognitive level.
|
Dement Geriatr Cogn Disord
|
2012
|
0.85
|
|
32
|
Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study.
|
Clin Interv Aging
|
2013
|
0.83
|
|
33
|
Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
|
Dement Geriatr Cogn Disord
|
2011
|
0.83
|
|
34
|
Soluble adhesion molecules and angiotensin-converting enzyme in dementia.
|
Neurobiol Dis
|
2007
|
0.83
|
|
35
|
Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders.
|
Dement Geriatr Cogn Disord
|
2013
|
0.82
|
|
36
|
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
|
BMC Neurol
|
2014
|
0.82
|
|
37
|
Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests.
|
Int J Geriatr Psychiatry
|
2009
|
0.81
|
|
38
|
Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up.
|
Dement Geriatr Cogn Disord
|
2014
|
0.80
|
|
39
|
alpha-Synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies.
|
Int Psychogeriatr
|
2009
|
0.80
|
|
40
|
Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates.
|
Int J Alzheimers Dis
|
2011
|
0.80
|
|
41
|
Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease.
|
J Neural Transm (Vienna)
|
2011
|
0.80
|
|
42
|
The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia.
|
Int J Geriatr Psychiatry
|
2010
|
0.79
|
|
43
|
Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies.
|
Int J Geriatr Psychiatry
|
2014
|
0.78
|
|
44
|
Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies.
|
Int J Geriatr Psychiatry
|
2012
|
0.78
|
|
45
|
Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia.
|
Curr Alzheimer Res
|
2012
|
0.77
|
|
46
|
Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services.
|
Dement Geriatr Cogn Disord
|
2015
|
0.77
|
|
47
|
CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.
|
Neurobiol Aging
|
2008
|
0.77
|
|
48
|
A longitudinal study of physical function in patients with early-onset dementia.
|
Dement Geriatr Cogn Dis Extra
|
2012
|
0.77
|
|
49
|
CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly.
|
Dement Geriatr Cogn Disord
|
2012
|
0.77
|
|
50
|
A new automated method for analysis of rCBF-SPECT images based on the active-shape algorithm: normal values.
|
Clin Physiol Funct Imaging
|
2011
|
0.77
|
|
51
|
No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias.
|
Neurosci Lett
|
2012
|
0.75
|
|
52
|
A pilot study examining associations between DYRK1A and α-synuclein dementias.
|
Neurodegener Dis
|
2012
|
0.75
|
|
53
|
[Lewy body dementia--big risk of wrong treatment and death].
|
Lakartidningen
|
2009
|
0.75
|
|
54
|
The usefulness of cube copying for evaluating treatment of Alzheimer's disease.
|
Am J Alzheimers Dis Other Demen
|
2009
|
0.75
|